Inventor · disambiguated record

Daisuke Kameoka

Also filed as: KAMEOKA DAISUKE

13 granted patents·9 pending applications·152 citations·filing 2002–2025

92Inventor score

Technology areasC07K A61K A61P

Files withCHUGAI PHARMACEUTICAL CO LTD16 MORICHIKA TOSHIYUKI2 HOFFMANN LA ROCHE1 IGAWA TOMOYUKI1 KAMEOKA DAISUKE1

Top patents by PatentIndex Score

22 records

0195US11767363B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 26, 2023·2 cites·6 claims
0295US11584798B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Feb 21, 2023·2 cites·6 claims
0394US11359026B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jun 14, 2022·2 cites·2 claims
0494US11260125B2Anti-IL31RA antibody-containing formulationsCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 1, 2022·4 cites·28 claims
0594US11008394B2High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 18, 2021·6 cites·16 claims
0694US10316096B2Stabilized antibody-containing formulationsCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 11, 2019·12 cites·10 claims
0794US9084777B2Stabilized antibody-containing formulationsMORICHIKA TOSHIYUKI·Filed 2006·Granted Jul 21, 2015·40 cites·6 claims
0894US8568720B2High concentration antibody-containing liquid formulationMORICHIKA TOSHIYUKI·Filed 2008·Granted Oct 29, 2013·53 cites·2 claims
0993US11723976B2Methods of administering anti-IL31A antibody-containing formulationsCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Aug 15, 2023·2 cites·30 claims
1092US8945543B2Stabilizer for protein preparation comprising meglumine and use thereofIGAWA TOMOYUKI·Filed 2006·Granted Feb 3, 2015·25 cites·8 claims
1190US2024376219A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
1290US2024392017A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
1389US12171830B2Anti-IL-31RA antibody-containing formulationsCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 24, 2024·1 cites·24 claims
1489US2024317869A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
1587US2023340134A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
1684US2025257144A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
1783US2025064930A1Anti-il-31ra antibody-containing formulationsCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
1877US10898572B2Stable protein-containing preparation containing argininamide or analogous compound thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jan 26, 2021·2 cites·24 claims
1965US9574005B2Stable Protein-containing preparation containing argininamide or analogous compound thereofKAMEOKA DAISUKE·Filed 2012·Granted Feb 21, 2017·1 cites·6 claims
2064US2014005367A1High concentration antibody-containing liquid formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
2161US2016090419A1High concentration antibody-containing liquid formulationHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
2247US2004156835A1Protein preparationFiled 2002·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Daisuke Kameoka files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →